About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming the treatment landscape for central nervous system (CNS) disorders. Our commitment to innovation drives us to recognize significant unmet needs in patient care and create unique solutions that focus on groundbreaking mechanisms of action, ultimately enhancing patient outcomes. Our esteemed neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, migraine conditions, and a variety of late-stage development initiatives targeting a wide array of serious neurological and psychiatric disorders affecting over 150 million individuals in the United States. Together, we strive to tackle some of the most challenging issues related to brain health, enabling patients and their families to thrive. Discover more at www.axsome.com and connect with us on LinkedIn.

